Utah Medical Products, Inc. (UTMD)
USD 53.55
(-1.54%)
USD 53.55
(-1.54%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 16.63 Million USD | 0.98% |
| 2022 | 16.47 Million USD | 11.39% |
| 2021 | 14.78 Million USD | 36.95% |
| 2020 | 10.79 Million USD | -26.68% |
| 2019 | 14.72 Million USD | -20.63% |
| 2018 | 18.55 Million USD | 118.15% |
| 2017 | 8.5 Million USD | -29.87% |
| 2016 | 12.12 Million USD | 2.41% |
| 2015 | 11.84 Million USD | 4.09% |
| 2014 | 11.37 Million USD | -0.25% |
| 2013 | 11.4 Million USD | 12.16% |
| 2012 | 10.16 Million USD | 37.16% |
| 2011 | 7.41 Million USD | 23.28% |
| 2010 | 6.01 Million USD | -3.9% |
| 2009 | 6.25 Million USD | -13.14% |
| 2008 | 7.2 Million USD | -8.86% |
| 2007 | 7.9 Million USD | -3.22% |
| 2006 | 8.16 Million USD | 8.23% |
| 2005 | 7.54 Million USD | -26.15% |
| 2004 | 10.22 Million USD | -50.77% |
| 2003 | 20.76 Million USD | 189.76% |
| 2002 | 7.16 Million USD | 20.74% |
| 2001 | 5.93 Million USD | 10.44% |
| 2000 | 5.37 Million USD | -1.74% |
| 1999 | 5.46 Million USD | 11.59% |
| 1998 | 4.9 Million USD | 13.95% |
| 1997 | 4.3 Million USD | -51.14% |
| 1996 | 8.8 Million USD | 4.76% |
| 1995 | 8.4 Million USD | 18.31% |
| 1994 | 7.1 Million USD | 1.43% |
| 1993 | 7 Million USD | 1.45% |
| 1992 | 6.9 Million USD | 27.78% |
| 1991 | 5.4 Million USD | 25.58% |
| 1990 | 4.3 Million USD | 65.38% |
| 1989 | 2.6 Million USD | 85.71% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 3.56 Million USD | 3.21% |
| 2024 Q2 | 3.45 Million USD | -12.71% |
| 2024 Q1 | 3.95 Million USD | -7.7% |
| 2023 Q2 | 4.2 Million USD | -0.33% |
| 2023 FY | 16.63 Million USD | 0.98% |
| 2023 Q3 | 3.93 Million USD | -6.31% |
| 2023 Q4 | 4.28 Million USD | 8.92% |
| 2023 Q1 | 4.21 Million USD | -7.49% |
| 2022 FY | 16.47 Million USD | 11.39% |
| 2022 Q1 | 3.53 Million USD | -14.45% |
| 2022 Q4 | 4.55 Million USD | 6.43% |
| 2022 Q2 | 4.1 Million USD | 16.1% |
| 2022 Q3 | 4.28 Million USD | 4.31% |
| 2021 Q1 | 3.02 Million USD | -11.37% |
| 2021 FY | 14.78 Million USD | 36.95% |
| 2021 Q4 | 4.13 Million USD | -1.78% |
| 2021 Q3 | 4.2 Million USD | 22.77% |
| 2021 Q2 | 3.42 Million USD | 13.29% |
| 2020 FY | 10.79 Million USD | -26.68% |
| 2020 Q1 | 3.14 Million USD | -27.97% |
| 2020 Q3 | 2.93 Million USD | 90.83% |
| 2020 Q4 | 3.41 Million USD | 16.33% |
| 2020 Q2 | 1.53 Million USD | -51.05% |
| 2019 Q4 | 4.35 Million USD | 17.65% |
| 2019 Q1 | 3.13 Million USD | -7.49% |
| 2019 FY | 14.72 Million USD | -20.63% |
| 2019 Q2 | 3.52 Million USD | 12.3% |
| 2019 Q3 | 3.7 Million USD | 5.11% |
| 2018 FY | 18.55 Million USD | 118.15% |
| 2018 Q1 | 4.09 Million USD | 262.25% |
| 2018 Q3 | 6.76 Million USD | 56.96% |
| 2018 Q4 | 3.39 Million USD | -49.82% |
| 2018 Q2 | 4.3 Million USD | 5.28% |
| 2017 Q4 | -2.52 Million USD | -169.63% |
| 2017 Q2 | 3.87 Million USD | 9.45% |
| 2017 FY | 8.5 Million USD | -29.87% |
| 2017 Q1 | 3.53 Million USD | 30.14% |
| 2017 Q3 | 3.62 Million USD | -6.41% |
| 2016 FY | 12.12 Million USD | 2.41% |
| 2016 Q1 | 3.21 Million USD | 0.19% |
| 2016 Q2 | 3.25 Million USD | 1.31% |
| 2016 Q3 | 2.93 Million USD | -9.94% |
| 2016 Q4 | 2.71 Million USD | -7.43% |
| 2015 Q3 | 3.04 Million USD | 4.42% |
| 2015 FY | 11.84 Million USD | 4.09% |
| 2015 Q2 | 2.91 Million USD | 9.41% |
| 2015 Q1 | 2.66 Million USD | -11.1% |
| 2015 Q4 | 3.21 Million USD | 5.38% |
| 2014 Q2 | 2.83 Million USD | 4.11% |
| 2014 Q4 | 3 Million USD | 6.31% |
| 2014 FY | 11.37 Million USD | -0.25% |
| 2014 Q3 | 2.82 Million USD | -0.42% |
| 2014 Q1 | 2.72 Million USD | -21.51% |
| 2013 Q1 | 2.73 Million USD | 21.07% |
| 2013 FY | 11.4 Million USD | 12.16% |
| 2013 Q2 | 2.63 Million USD | -3.77% |
| 2013 Q3 | 2.57 Million USD | -2.32% |
| 2013 Q4 | 3.46 Million USD | 34.89% |
| 2012 Q1 | 2.78 Million USD | 50.11% |
| 2012 FY | 10.16 Million USD | 37.16% |
| 2012 Q3 | 2.72 Million USD | 13.33% |
| 2012 Q2 | 2.4 Million USD | -13.91% |
| 2012 Q4 | 2.25 Million USD | -16.98% |
| 2011 Q1 | 1.33 Million USD | -11.46% |
| 2011 Q4 | 1.85 Million USD | -16.94% |
| 2011 Q2 | 1.98 Million USD | 48.35% |
| 2011 Q3 | 2.23 Million USD | 12.87% |
| 2011 FY | 7.41 Million USD | 23.28% |
| 2010 FY | 6.01 Million USD | -3.9% |
| 2010 Q4 | 1.5 Million USD | -0.2% |
| 2010 Q3 | 1.51 Million USD | 3.07% |
| 2010 Q2 | 1.46 Million USD | -3.93% |
| 2010 Q1 | 1.52 Million USD | -1.29% |
| 2009 Q4 | 1.54 Million USD | -4.21% |
| 2009 FY | 6.25 Million USD | -13.14% |
| 2009 Q3 | 1.61 Million USD | 7.38% |
| 2009 Q2 | 1.5 Million USD | -5.53% |
| 2009 Q1 | 1.59 Million USD | 0.95% |
| 2008 Q1 | 1.89 Million USD | -3.27% |
| 2008 Q3 | 1.82 Million USD | -5.06% |
| 2008 Q4 | 1.57 Million USD | -13.35% |
| 2008 FY | 7.2 Million USD | -8.86% |
| 2008 Q2 | 1.91 Million USD | 1.37% |
| 2007 FY | 7.9 Million USD | -3.22% |
| 2007 Q4 | 1.95 Million USD | -3.27% |
| 2007 Q3 | 2.02 Million USD | 1.81% |
| 2007 Q2 | 1.98 Million USD | 2.11% |
| 2007 Q1 | 1.94 Million USD | -6.09% |
| 2006 FY | 8.16 Million USD | 8.23% |
| 2006 Q1 | 2.03 Million USD | 7.05% |
| 2006 Q2 | 2.05 Million USD | 1.13% |
| 2006 Q4 | 2.07 Million USD | 3.34% |
| 2006 Q3 | 2 Million USD | -2.72% |
| 2005 FY | 7.54 Million USD | -26.15% |
| 2005 Q4 | 1.9 Million USD | 6.32% |
| 2005 Q3 | 1.78 Million USD | -5.19% |
| 2005 Q2 | 1.88 Million USD | -4.16% |
| 2005 Q1 | 1.96 Million USD | 40.94% |
| 2004 Q2 | 1.84 Million USD | -64.43% |
| 2004 Q3 | 1.8 Million USD | -1.85% |
| 2004 Q4 | 1.39 Million USD | -22.69% |
| 2004 FY | 10.22 Million USD | -50.77% |
| 2004 Q1 | 5.17 Million USD | -66.12% |
| 2003 Q2 | 1.83 Million USD | 2.74% |
| 2003 Q4 | 15.27 Million USD | 720.8% |
| 2003 FY | 20.76 Million USD | 189.76% |
| 2003 Q1 | 1.78 Million USD | 0.17% |
| 2003 Q3 | 1.86 Million USD | 1.31% |
| 2002 FY | 7.16 Million USD | 20.74% |
| 2002 Q1 | 1.71 Million USD | 11.82% |
| 2002 Q2 | 1.78 Million USD | 4.26% |
| 2002 Q3 | 1.88 Million USD | 5.49% |
| 2002 Q4 | 1.78 Million USD | -5.2% |
| 2001 Q2 | 1.48 Million USD | 6.47% |
| 2001 Q3 | 1.53 Million USD | 3.44% |
| 2001 Q4 | 1.53 Million USD | -0.07% |
| 2001 FY | 5.93 Million USD | 10.44% |
| 2001 Q1 | 1.39 Million USD | 2.73% |
| 2000 Q2 | 1.38 Million USD | 12.81% |
| 2000 Q3 | 1.41 Million USD | 1.95% |
| 2000 Q4 | 1.35 Million USD | -3.97% |
| 2000 Q1 | 1.22 Million USD | -16.49% |
| 2000 FY | 5.37 Million USD | -1.74% |
| 1999 Q2 | 1.3 Million USD | 8.33% |
| 1999 Q3 | 1.5 Million USD | 15.38% |
| 1999 Q4 | 1.46 Million USD | -2.13% |
| 1999 Q1 | 1.2 Million USD | -7.69% |
| 1999 FY | 5.46 Million USD | 11.59% |
| 1998 Q4 | 1.3 Million USD | 0.0% |
| 1998 FY | 4.9 Million USD | 13.95% |
| 1998 Q1 | 1.2 Million USD | 0.0% |
| 1998 Q2 | 1.1 Million USD | -8.33% |
| 1998 Q3 | 1.3 Million USD | 18.18% |
| 1997 Q2 | 900 Thousand USD | -10.0% |
| 1997 Q4 | 1.2 Million USD | 0.0% |
| 1997 Q3 | 1.2 Million USD | 33.33% |
| 1997 FY | 4.3 Million USD | -51.14% |
| 1997 Q1 | 1 Million USD | -50.0% |
| 1996 FY | 8.8 Million USD | 4.76% |
| 1996 Q4 | 2 Million USD | -9.09% |
| 1996 Q3 | 2.2 Million USD | 0.0% |
| 1996 Q2 | 2.2 Million USD | -12.0% |
| 1996 Q1 | 2.5 Million USD | 8.7% |
| 1995 Q1 | 1.8 Million USD | 0.0% |
| 1995 Q2 | 2.1 Million USD | 16.67% |
| 1995 FY | 8.4 Million USD | 18.31% |
| 1995 Q4 | 2.3 Million USD | 4.55% |
| 1995 Q3 | 2.2 Million USD | 4.76% |
| 1994 Q1 | 1.7 Million USD | 6.25% |
| 1994 FY | 7.1 Million USD | 1.43% |
| 1994 Q4 | 1.8 Million USD | 0.0% |
| 1994 Q3 | 1.8 Million USD | 0.0% |
| 1994 Q2 | 1.8 Million USD | 5.88% |
| 1993 Q3 | 1.8 Million USD | 5.88% |
| 1993 Q4 | 1.6 Million USD | -11.11% |
| 1993 Q1 | 1.8 Million USD | -10.0% |
| 1993 FY | 7 Million USD | 1.45% |
| 1993 Q2 | 1.7 Million USD | -5.56% |
| 1992 FY | 6.9 Million USD | 27.78% |
| 1992 Q3 | 1.9 Million USD | 18.75% |
| 1992 Q1 | 1.4 Million USD | -12.5% |
| 1992 Q4 | 2 Million USD | 5.26% |
| 1992 Q2 | 1.6 Million USD | 14.29% |
| 1991 Q2 | 1.2 Million USD | 9.09% |
| 1991 FY | 5.4 Million USD | 25.58% |
| 1991 Q4 | 1.6 Million USD | 6.67% |
| 1991 Q3 | 1.5 Million USD | 25.0% |
| 1991 Q1 | 1.1 Million USD | -15.38% |
| 1990 Q3 | 1.3 Million USD | 44.44% |
| 1990 Q2 | 900 Thousand USD | 12.5% |
| 1990 Q1 | 800 Thousand USD | -11.11% |
| 1990 Q4 | 1.3 Million USD | 0.0% |
| 1990 FY | 4.3 Million USD | 65.38% |
| 1989 Q4 | 900 Thousand USD | 12.5% |
| 1989 Q2 | 500 Thousand USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q3 | 800 Thousand USD | 60.0% |
| 1989 FY | 2.6 Million USD | 85.71% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 126.27% |
| AngioDynamics, Inc. | -184.34 Million USD | 109.024% |
| AtriCure, Inc. | -30.43 Million USD | 154.652% |
| Avinger, Inc. | -18.32 Million USD | 190.802% |
| Azenta, Inc. | -14.25 Million USD | 216.68% |
| BioLife Solutions, Inc. | -66.42 Million USD | 125.043% |
| The Cooper Companies, Inc. | 294.2 Million USD | 94.346% |
| Daxor Corporation | 280.64 Thousand USD | -5827.523% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 209.455% |
| Femasys Inc. | -14.24 Million USD | 216.76% |
| GlucoTrack, Inc. | -7.09 Million USD | 334.395% |
| Harvard Bioscience, Inc. | -3.41 Million USD | 587.116% |
| Hologic, Inc. | 789.5 Million USD | 97.893% |
| ICU Medical, Inc. | -29.65 Million USD | 156.095% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 99.075% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 221.061% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 44.743% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 349.646% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 349.646% |
| Masimo Corporation | 81.5 Million USD | 79.589% |
| Microbot Medical Inc. | -10.74 Million USD | 254.888% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | -43.092% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 82.38% |
| Nephros, Inc. | -1.57 Million USD | 1156.19% |
| NovoCure Limited | -207.04 Million USD | 108.035% |
| NEXGEL, Inc. | -3.15 Million USD | 626.924% |
| NEXGEL, Inc. | -3.15 Million USD | 626.924% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 117.544% |
| OraSure Technologies, Inc. | 53.65 Million USD | 68.996% |
| Pro-Dex, Inc. | 2.12 Million USD | -682.087% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 139.41% |
| Predictive Oncology Inc. | -13.98 Million USD | 218.958% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | 663.635% |
| QuidelOrtho Corporation | -10.1 Million USD | 264.703% |
| Repligen Corporation | 41.57 Million USD | 59.99% |
| Sanara MedTech Inc. | -4.3 Million USD | 486.573% |
| STAAR Surgical Company | 21.34 Million USD | 22.073% |
| Sharps Technology, Inc. | -9.84 Million USD | 269.027% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 112.602% |
| Jin Medical International Ltd. | 2.87 Million USD | -477.959% |